Challenge models to assess new therapies in chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality. Current therapies confer partial benefits either by incompletely improving airflow limitation or by reducing acute exacerbations, hence new therapies are desirable. In the absence of robust early predictors of...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Merwe, René, Molfino, Nestor A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459659/
https://www.ncbi.nlm.nih.gov/pubmed/23055710
http://dx.doi.org/10.2147/COPD.S30664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459659/
https://www.ncbi.nlm.nih.gov/pubmed/23055710
http://dx.doi.org/10.2147/COPD.S30664

Ejemplares similares